X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

HALO

Closed

Halozyme Therapeutics Inc

52.92
+0.90 (+1.73%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 52.02
Day's Range: 51.78 - 53.3124
Send
When Written:
 
38.39
Halozyme Therapeutics Inc. is a biotechnology company that develops and commercializes novel oncology therapies and drug delivery technologies. The company's proprietary enzyme platform technology, known as Enhanze, is used to enhance the delivery and efficacy of biologics, including monoclonal antibodies and therapeutic proteins. Halozyme also has a pipeline of proprietary oncology therapies, including PEGPH20, a novel enzyme that targets the tumor microenvironment and is being developed for the treatment of pancreatic cancer. The company is headquartered in San Diego, California and was founded in 1998.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X